Perspectives and Insights on Lipid Modifying Drugs (C10): From Development to New Drug Submission (NDS) Application to Health Canada
Bibliographic record
Abstract
Lipid-modifying agents, classified under ATC code C10, are essential for managing dyslipidemia, a primary risk factor for cardiovascular diseases (CVDs), which remain a leading cause of morbidity and mortality in Canada. These therapies reduce low-density lipoprotein cholesterol (LDL-C), triglycerides, and elevate high-density lipoprotein cholesterol (HDL-C), mitigating atherosclerosis and cardiovascular events. While statins dominate treatment, novel agents, including monoclonal antibodies, small molecules, and RNA interference therapies, address limitations like statin intolerance and residual risk. This article provides a comprehensive analysis of the C10 therapeutic class, detailing clinical applications, chemical properties, packaging systems, safety profiles, and emerging technologies. It also outlines the regulatory pathway for preparing a New Drug Submission (NDS) in Canada, aligning with the Food and Drugs Act, Health Canada regulations, and International Council for Harmonisation (ICH) guidelines. Recommendations emphasize early regulatory engagement, robust pharmacovigilance, and equitable access to enhance CVD prevention.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.001 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".